Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,664.00    -4.00 (-0.24%)
Bid:
1,662.00
Ask:
1,668.00
Spread: 6.00 (0.361%)
Market Cap: £490.08m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

U.S. Army Body Armor Contract Award

2 Mar 2020 07:00

RNS Number : 5933E
Avon Rubber PLC
02 March 2020
Β 

2 March 2020

Avon Rubber p.l.c.

U.S. Army Body Armor Contract Award

Β 

Avon Rubber p.l.c. is pleased to confirm the award of a four year, dual source framework contract to supply the U.S. Army with next generation Vital Torso Protection ("VTP") X-Side Ballistic Insert ("XSBI") body armor plates.

Β 

Under the terms of the framework agreement, Avon Protection will compete for each order of the $265 million contract. Deliveries of the initial orders are expected to commence in our 2021 financial year following receipt of product approvals.

Β 

The XSBI plates are one of a number of VTP body armor products developed by 3M's ballistic-protection business, which Avon Protection acquired on 2 January 2020, that form part of the U.S. Army's Soldier Protection System. Together with the existing $704 million four year multi source framework contract to supply the U.S. Army with Enhanced Small Arms Protective Insert and X-Small Arms Protective Insert body armor plates, this contract reflects Avon Protection's leading market position and underpins our expected medium term revenues.

Β 

Commenting, Paul McDonald, Chief Executive Officer, said:

Β 

"This is another significant, multi-year contract for Avon Protection and demonstrates our position as a leading provider of next generation body armor to the U.S. armed forces.

Β 

This further strengthens the medium term outlook and visibility for Avon Protection and represents encouraging momentum in our newly acquired ballistic protection business."

Β 

For further enquiries, please contact:

Β 

Avon Rubber p.l.c.

Paul McDonald, Chief Executive Officer

01225 896 848

Nick Keveth, Chief Financial Officer

Ryan Mahoney, Deputy Chief Financial Officer

MHP Communications

Andrew Jaques

0203 128 8570

Charlie Barker

avonrubber@mhpc.com

Pete Lambie

Ailsa Prestige

Β 

Legal Entity Identifier: 213800JM1AN62REBWA71

Note to editors:Β 

Avon Rubber is an innovative technology group, which designs and produces specialist products and services to maximise the performance and capabilities of its customers. We specialise in life critical personal protection systems, as well as milking point solutions through our two businesses, Avon Protection and milkrite | InterPuls.

Β 

Avon Protection is a recognised global leader in respiratory and ballistic protection for the world's Militaries and First Responders.

Β 

milkrite | InterPuls is a global leader providing complete milking point solutions to dairy farmers across the world with the aim of improving every farm it touches.

Β 

For further information, please visit our website: www.avon-rubber.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
MSCJBMTTMTBMTFM
Date   Source Headline
8th Jun 20261:37 pmRNSDirector/PDMR Shareholding
13th May 20267:00 amRNSInterim Results
8th May 20267:00 amRNSHolding(s) in Company
6th May 20262:03 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSHolding(s) in Company
14th Apr 20267:00 amRNSNotice of Results and Investor Presentation
8th Apr 202612:15 pmRNSHolding(s) in Company
8th Apr 202611:47 amRNSDirector/PDMR Shareholding
27th Mar 20261:23 pmRNSDirector/PDMR Shareholding
6th Mar 20261:23 pmRNSDirectors'/PDMR Shareholdings
6th Mar 20267:00 amRNSNew Filter Order
3rd Mar 20262:34 pmRNSHolding(s) in Company
13th Feb 202611:01 amRNSDirector/PDMR Shareholding
6th Feb 20262:52 pmRNSDirectors'/PDMR Shareholdings
6th Feb 20262:41 pmRNSFinal Dividend Currency Exchange Rate
4th Feb 20264:18 pmRNSHolding(s) in Company
2nd Feb 202610:10 amRNSResult of AGM
30th Jan 20267:00 amRNSAGM & Q1 Trading Update
20th Jan 20263:19 pmRNSDirector/PDMR Shareholding
6th Jan 20261:46 pmRNSDirectors'/PDMR Shareholdings
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
16th Dec 20258:45 amRNSHolding(s) in Company
11th Dec 20253:51 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSEuropean FM50 Order
9th Dec 202511:58 amRNSDirectors'/PDMR Shareholding
8th Dec 20251:32 pmRNSDirectors'/PDMR Shareholdings
5th Dec 20259:00 amRNSNotice of Annual Report & Accounts and AGM 2026
1st Dec 20256:01 pmRNSDirector Declaration
25th Nov 20253:55 pmRNSHolding(s) in Company
21st Nov 20259:50 amRNSNotification of LTIP & DSBP Awards
12th Nov 20257:00 amRNSPreliminary Results
7th Nov 20259:23 amRNSDirectors'/PDMR Shareholdings
16th Oct 20257:00 amRNSNotice of Results & Investor Presentation via IMC
8th Oct 202510:06 amRNSDirectors'/PDMR Shareholding
15th Sep 20252:51 pmRNSHolding(s) in Company
11th Sep 20254:10 pmRNSHolding(s) in Company
8th Sep 20251:14 pmRNSDirectors'/PDMR Shareholding
13th Aug 20254:59 pmRNSInterim Dividend Currency Exchange Rate
11th Aug 20254:47 pmRNSHolding(s) in Company
7th Aug 20253:10 pmRNSDirectors'/PDMR Shareholdings
17th Jul 20257:00 amRNSDirectors'/PDMR Shareholdings
23rd Jun 20257:00 amRNSUK MoD respirator order for Ukraine
10th Jun 20257:00 amRNSHolding(s) in Company
9th Jun 20259:30 amRNSDirectors'/PDMR Shareholdings
5th Jun 20253:31 pmRNSUS Department of Defense Order
3rd Jun 20256:00 pmRNSRenewi
29th May 202510:00 amRNSHolding(s) in Company
21st May 20257:00 amRNSInterim Results
20th May 20254:00 pmRNSNotification of change in particulars of director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.